Risk of Nerve Damage After Administration of Local Anesthesia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.
Epistemonikos ID: 0e33bf04ce8615616f079af67325f5edee46780a
First added on: Apr 17, 2025